The Top 10 Things Nephrologists Wish Every Primary Care Physician Knew

Paige, Neil M.; Nagami, Glenn T.
February 2009
Mayo Clinic Proceedings;Feb2009, Vol. 84 Issue 2, p180
Academic Journal
Renal disease is commonly encountered by primary care physicians during their day-to-day visits with patients. Common renal disorders include hypertension, proteinuria, kidney stones, and chronic kidney disease. Despite their prevalence, many physicians may be unfamiliar with the diagnosis and initial treatment of these common renal disorders. Early recognition and intervention are important In slowing the progression of chronic kidney disease and preventing its complications. The evidence-based pearls in this article will help primary care physicians avoid common pitfalls in the recognition and treatment of such disorders and guide their decision to refer their patients to a specialist.


Related Articles

  • Dual blockade of the rennin—angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Mori-Takeyama, Urara; Minatoguchi, Shinya; Murata, Ichijirou; Fujiwara, Hisayoshi; Ozaki, Yoko; Ohno, Michiya; Oda, Hiroshi; Ohashi, Hiroshige // Clinical & Experimental Nephrology;Feb2008, Vol. 12 Issue 1, p33 

    Proteinuria and hypertension are predictors of poor renal outcome in chronic glomerulonephritis (CGN). At the same level of blood pressure (BP) control, we evaluated which is superior, dual blockade of the rennin–angiotensin system (RAS) with both angiotensin-converting enzyme inhibitor...

  • FIRST COMMUNITY-BASED SCREENING FOR CHRONIC KIDNEY DISEASE, HYPERTENSION AND DIABETES IN DHARAN, NEPAL. K., Sharma S.; P., Karki; R., Shrestha N.; L., Thapa; S., Chaudhary; R., Tamrakar; S., Dhakal; R., Deo; N., Baral; R., Maskey; M., Parajuli; S., Kumar // Indian Journal of Nephrology;Jul-Sep2007, Vol. 17 Issue 3, p113 

    Aims: Nepal cannot afford renal replacement therapy (RRT) for ESRD due to lack of resources. Early diagnosis of CKD and its risk factors may reduce the need of RRT. Materials and Methods: In this first community-based screening program in Nepal, 3218 people iÝ 20 years were assessed by...

  • Synergistic QTL interactions between Rf-1 and Rf-3 increase renal damage susceptibility in double congenic rats. Van Dijk, S. J.; Specht, P. A. C.; Lazar, J.; Jacob, H. J.; Provoost, A. P. // Kidney International;Apr2006, Vol. 69 Issue 8, p1369 

    The FHH (fawn-hooded hypertensive) rat is a model of hypertension-associated chronic kidney damage. Five interacting quantitative trait loci (QTLs), named Rf-1–Rf-5, determine the high renal susceptibility. The aim of the present study was to investigate a possible interaction between...

  • Influence of Glycaemic Control on Proteinuria in Patients with Type 2 Diabetes and Overt Nephropathy and Hypertension: Results of the AMADEO Trial. Bakris, George; Burgess, Ellen; Weir, Matthew; Koval, Stephen // Diabetes;Jun2007 Supplement 1, Vol. 56, pA159 

    End-stage renal disease (ESRD) in patients with type 2 diabetes is a worldwide medical problem. The AMADEO study compared the long-term antiproteinuric effect of telmisartan versus losartan (an angiotensin receptor blocker [ARB] with an indication to slow diabetic nephropathy progression). This...

  • OPTIMAL TREATMENT IN RENOPARENCHYMATOUS ARTERIAL HYPERTENSION AND CHRONIC RENAL FAILURE. Liga, Georgeta; Checheriţă, I. Al.; Sandulovici, Roxana C.; Niculae, A.; Rădulescu, Daniela; Ciocălteu, Al. // Therapeutics, Pharmacology & Clinical Toxicology;2010, Vol. 14 Issue 4, p263 

    Chronic renal diseases are often accompanied by systemic hypertension, which, in turn, accelerates progression of renal dysfunction. The vast majority of actual guidelines recommend ACEI and/ or ARB as first choice of antihypertensive treatment. The study presented compares the evolution of 157...

  • Collagen type III glomerulopathy: A case report and review of 20 cases. JUNWU DONG; HONGLAN WEI; MIN HAN; YANG GUAN; YANG WU; HUA LI // Experimental & Therapeutic Medicine;Oct2015, Vol. 10 Issue 4, p1445 

    Collagen type III glomerulopathy is a non-immune-mediated glomerular disease, characterized by abnormal accumulation of type III collagen fibrils within the mesangial matrix and subendothelial space. The clinical manifestations of this disease are proteinuria, peripheral edema, hypertension and...

  • Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Ayinuer Adijiang; Sumie Goto; Satsuki Uramoto; Fuyuhiko Nishijima; Toshimitsu Niwa // Nephrology Dialysis Transplantation;Jun2008, Vol. 23 Issue 6, p1892 

    Background. Stage 5 chronic kidney disease (CKD) is associated with enhanced aortic calcification. The aim of this study was to determine if the administration of indoxyl sulphate (IS), a uraemic toxin, stimulates the progression of aortic calcification. Methods. The rat groups consisted of (i)...

  • The Quiet Killer. O. Z., Mehmet // O, The Oprah Magazine;Oct2010, Vol. 11 Issue 10, p154 

    In this article, the author reports on chronic kidney disease (CKD), a life-threatening disease that afflicts millions of people in the U.S. CKD occurs when over the course of several months to years, the organs' tiny filters are progressively damaged. Diabetes and hypertension, together account...

  • Postpartum renal insufficiency. Ferris, Thomas F. // Kidney International;Oct1978, Vol. 14 Issue 4, p383 

    Presents the case of an 18-year-old who was admitted to the New England Medical Center Hospital for the management of postpartum renal insufficiency. Development of a proteinuria and mild hypertension at her sixth month of pregnancy; Results of the physical examination of the patient;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics